Nel ASA's Leadership Gambit Precedes a Critical Financial Test

Nel ASA shares gain as investors back a new performance-based pay plan. The hydrogen firm now faces a crucial Q1 earnings test to prove it can convert its large order backlog into revenue.

As Norway's broader market dipped on Tuesday, shares of hydrogen specialist Nel ASA defied the trend, climbing 2.64 percent to 0.19 euros. This uptick, which nudges the stock away from its 52-week low of 0.18 euros marked in early March, comes directly on the heels of a pivotal annual general meeting in Oslo. Investors endorsed a sweeping overhaul of executive compensation, signaling a shift in governance just weeks before a crucial earnings report.

The company is now in a mandatory quiet period ahead of its first-quarter results, due on April 22. This silence creates an uneasy wait for shareholders who have endured months of anticipation for a tangible financial breakthrough. The upcoming report is viewed as a decisive test of whether the company can finally translate a surge of new orders into meaningful revenue.

A Strategic Compensation Overhaul

At the heart of the recent shareholder meeting was a radical restructuring of management pay. The previous stock option program has been replaced with a purely performance-based model, directly tying executive rewards to long-term value creation. The total package involves issuing 14,933,025 new Performance Share Units (PSUs).

Notably, CEO Håkon Volldal voluntarily surrendered 1,500,000 old options in exchange for 1,159,173 of the new PSUs. CFO Kjell Christian Bjørnsen also returned his existing options to transition into the new system. The allocation of these shares will be staggered over a three-year period, aligning management interests with patient capital.

The Persistent Gap Between Orders and Revenue

This leadership realignment unfolds against a backdrop of stark financial contrasts. Nel's 2025 results highlighted a significant disconnect. While order intake in the fourth quarter skyrocketed 364 percent to NOK 686 million—driven largely by a single major PEM electrolyser contract that accounted for 93 percent of new orders—revenue moved in the opposite direction. Customer contract revenue fell 20 percent in that same quarter.

For the full year 2025, revenue declined 31 percent, culminating in a net loss of NOK 1.27 billion, significantly impacted by asset impairments. Management has attributed the gap to irregular delivery schedules for large-scale projects, but investor patience is wearing thin. The total order backlog, however, remains robust at over NOK 1.3 billion.

A Dual-Path Future: New Tech and Old Liabilities

Strategically, Nel is pursuing two parallel tracks. The commercial launch of a new pressurised alkaline electrolyser platform is scheduled for the first half of 2026. Backed by EU funding of up to 135 million euros, the system is touted to be up to 60 percent cheaper to manufacture. Initial investments for gigawatt-scale production capacity are estimated at roughly NOK 300 million before subsidies, planned for 2026 and 2027.

Simultaneously, the company faces lingering risks at its Herøya facility. Management is reviewing the book values of two idled production lines, indicating potential for further impairment charges. Nel enters the second quarter with a liquidity reserve of approximately NOK 1.6 billion—deemed sufficient but not a comfortable buffer should losses persist.

Market Sentiment and the Road Ahead

Analyst sentiment remains cautious. Both Berenberg and Citi maintain "Hold" ratings, with price targets of NOK 2.30 and NOK 2.40, respectively. They cite the unpredictable conversion of orders into revenue and open questions about the market readiness of the new technology platform. The stock currently trades around NOK 2.16, close to its annual low of NOK 1.92.

The focus now shifts entirely to April 22. The first-quarter report must provide evidence that the strong order intake from late 2025 is finally feeding into the income statement. Failure to show progress could further erode confidence in the growth narrative. The next major data point arrives with the half-year report on July 15, leaving the market reliant on signals from this month's disclosure.